Washington, March 4 (IANS) The U.S. International Trade Commission (USITC) has received a complaint alleging that biosimilar versions of the cancer drug pertuzumab imported into the United States violate U.S. trade law. Several entities of India’s largest biopharmaceutical company, Biocon, have been named as respondents.The notice was published in the Federal Register. It said the complaint was filed by the world’s top biotech company, Genentech, on February 27, 2026.“The Commiss…
Trending
- Onekdin Por Review (2026): A Quietly Powerful Bengali Drama That Heals the Heart
- Carry On Jatta 4 Review (2026): Punjabi Comedy’s Most Beloved Franchise Returns With Even Bigger Laughs
- Moda Kavida Vaatavarana (2026) Review: Suni Weaves a Hauntingly Beautiful Monsoon Drama That Lingers Long After the Credits
- UYiR Movie Review (2026): Roshan Mathew Delivers a Gripping Performance in This Malayalam Crime Thriller
- Tera Mera Nata Review (2026): A Heartfelt Tale of Love, Family, and Sacrifice
- Heartin Movie Review: Sananth and Madonna Sebastian Deliver a Visually Stunning Tamil Romance Worth Your Time
- Risk – A Game of Youth Review: A Gritty Crime Drama That Takes Bold Chances With Youth and Ambition
- Balaramana Dinagalu Review: Vinod Prabhakar’s Gritty Gangster Drama Is a Compelling Ride Worth Watching